Abstract

Recent advancements in DNA sequencing methodologies and sequence data analysis have revolutionised research in many areas of biology and medicine, including veterinary infection biology. New technology is poised to bridge the gap between the research and diagnostic laboratory. This paper defines the potential diagnostic value and purposes of next-generation sequencing (NGS) applications in veterinary infection biology and explores their compatibility with the existing validation principles and methods of the World Organisation for Animal Health. Critical parameters for validation and quality control (quality metrics) are suggested, with reference to established validation and quality assurance guidelines for NGS-based methods of diagnosing human heritable diseases. Although most currently described NGS applications in veterinary infection biology are not primary diagnostic tests that directly result in control measures, this critical reflection on the advantages and remaining challenges of NGS technology should stimulate discussion on its diagnostic value and on the potential to validate NGS methods and monitor their diagnostic performance.

Keywords

Molecular diagnostics; Next-generation sequencing; Quality assurance; Validation

Published in

Revue Scientifique et Technique- Office International des Epizooties
2016, Volume: 35, number: 1, pages: 67-81
Publisher: OFFICE INT EPIZOOTIES

SLU Authors

• Granberg, Fredrik

  • Department of Animal Biosciences, Swedish University of Agricultural Sciences
    

UKÄ Subject classification

Microbiology
Pathobiology
Diagnostic Biotechnology


Publication identifier

DOI: https://doi.org/10.20506/rst.35.1.2418

Permanent link to this page (URI)

https://res.slu.se/id/publ/79568